BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18707545)

  • 1. High-expression of monoclonal nanobodies used in the preparation of HRP-conjugated second antibody.
    Ahmadvand D; Rahbarizadeh F; Vishteh VK
    Hybridoma (Larchmt); 2008 Aug; 27(4):269-76. PubMed ID: 18707545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris.
    Rahbarizadeh F; Rasaee MJ; Forouzandeh M; Allameh AA
    Mol Immunol; 2006 Feb; 43(5):426-35. PubMed ID: 16337485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of novel recombinant single-domain antibodies against tandem repeat region of MUC1 mucin.
    Rahbarizadeh F; Rasaee MJ; Forouzandeh Moghadam M; Allameh AA; Sadroddiny E
    Hybrid Hybridomics; 2004 Jun; 23(3):151-9. PubMed ID: 15312305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobody‑horseradish peroxidase and -EGFP fusions as reagents to detect porcine parvovirus in the immunoassays.
    Lu Q; Li X; Zhao J; Zhu J; Luo Y; Duan H; Ji P; Wang K; Liu B; Wang X; Fan W; Sun Y; Zhou EM; Zhao Q
    J Nanobiotechnology; 2020 Jan; 18(1):7. PubMed ID: 31910833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression and purification of the recombinant camelid anti-MUC1 single domain antibodies in Escherichia coli.
    Rahbarizadeh F; Rasaee MJ; Forouzandeh-Moghadam M; Allameh AA
    Protein Expr Purif; 2005 Nov; 44(1):32-8. PubMed ID: 15922625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of thermostability in Camelus bactrianus (Bactrian camel) single-domain antibody specific for the mutant epidermal-growth-factor receptor expressed by Pichia.
    Omidfar K; Rasaee MJ; Kashanian S; Paknejad M; Bathaie Z
    Biotechnol Appl Biochem; 2007 Jan; 46(Pt 1):41-9. PubMed ID: 16848761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and enzyme-conjugation of a specific anti-L1 nanobody.
    Minaeian S; Rahbarizadeh F; Zarkesh Esfahani SH; Ahmadvand D
    J Immunoassay Immunochem; 2012; 33(4):422-34. PubMed ID: 22963491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanobody-horseradish peroxidase fusion protein as an ultrasensitive probe to detect antibodies against Newcastle disease virus in the immunoassay.
    Sheng Y; Wang K; Lu Q; Ji P; Liu B; Zhu J; Liu Q; Sun Y; Zhang J; Zhou EM; Zhao Q
    J Nanobiotechnology; 2019 Mar; 17(1):35. PubMed ID: 30823927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
    Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobodies: natural single-domain antibodies.
    Muyldermans S
    Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanobody production can be simplified by direct secretion from Escherichia coli.
    Iwaki T; Hara K; Umemura K
    Protein Expr Purif; 2020 Jun; 170():105607. PubMed ID: 32062022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
    Xia X; M M; Zhai T; Li J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single domain camel antibodies: current status.
    Muyldermans S
    J Biotechnol; 2001 Jun; 74(4):277-302. PubMed ID: 11526908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in single-domain antibody derived from heavy-chain antibody].
    Cui HQ; Wang QM
    Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):497-501. PubMed ID: 16108383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells.
    Jamnani FR; Rahbarizadeh F; Shokrgozar MA; Ahmadvand D; Mahboudi F; Sharifzadeh Z
    Exp Cell Res; 2012 Jun; 318(10):1112-24. PubMed ID: 22440788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional mutations in and characterization of VHH against Helicobacter pylori urease.
    Hoseinpoor R; Mousavi Gargari SL; Rasooli I; Rajabibazl M; Shahi B
    Appl Biochem Biotechnol; 2014 Mar; 172(6):3079-91. PubMed ID: 24492955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The production and characterization of novel heavy-chain antibodies against the tandem repeat region of MUC1 mucin.
    Rahbarizadeh F; Rasaee MJ; Forouzandeh M; Allameh A; Sarrami R; Nasiry H; Sadeghizadeh M
    Immunol Invest; 2005; 34(4):431-52. PubMed ID: 16302687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of anti-digoxigenin antibody HRP conjugate for PCR-ELISA DIG detection system.
    Gill P; Forouzandeh M; Rahbarizadeh F; Ramezani R; Rasaee MJ
    J Immunoassay Immunochem; 2006; 27(4):303-18. PubMed ID: 16981644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies.
    Roovers RC; Laeremans T; Huang L; De Taeye S; Verkleij AJ; Revets H; de Haard HJ; van Bergen en Henegouwen PM
    Cancer Immunol Immunother; 2007 Mar; 56(3):303-317. PubMed ID: 16738850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.